Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Clinical trial NCT04042831 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04042831
Sponsor: Academic and Community Cancer Research United
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Adenocarcinoma Fanconi Anemia Complementation Group Gene Mutation Metastatic Bile Duct Carcinoma PTEN Gene Deletion

Start date: 2020-06-24
Primary completion: 2025-03-12
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.